TTRX Stock Price & Analysis — Turn Therapeutics Inc. Common Stock (Healthcare >> Biotechnology)
TTRX FAQ
What is TTRX's P/E ratio?
Turn Therapeutics Inc. Common Stock (TTRX) currently trades at a P/E ratio of 943.59.
What is TTRX's ROE?
Turn Therapeutics Inc. Common Stock reports a Return on Equity (ROE) of -62.71%.
What is TTRX's dividend yield?
Turn Therapeutics Inc. Common Stock offers a dividend yield of 0.00%.
What is TTRX's Quality Score?
Our AI rates TTRX's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy TTRX?
Our AI Timing Score for TTRX is 87 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does TTRX belong to?
Turn Therapeutics Inc. Common Stock is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange
TTRX AI Analysis Summary
Our AI summary for TTRX: Turn Therapeutics Inc. Common Stock (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 943.59, ROE of -62.71%, a dividend yield of 0.00%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 87/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 9.52
Price
0.68
(7.69%)
Day Change
|
|
|---|
TTRX, the overall quality is not good ( Quality = 38) but the timing to buy is ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
P/E ratio is relatively high
ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Negative growth of ROE in the last year.
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not quite good , and ability to make profit is not good , ...
| Quality Factors |
|
38% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 88 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 9.52 |
| PBV / Sector |
43.04 / 44,022.72
|
| Earning Per Share | -0.14 |
| PE / Sector |
943.59 / 19.17
|
| PEG or PE/Growth / Sector |
N/A / 1.24
|
| Average 1M Daily Value |
1.03 M
GREAT
|
| Average 1W Daily Value |
0.43 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
50% |
| Ability to Make Profit |
|
37% |
| Return to Investors |
|
8% |
| Registration Details |
| Analyze Date | 2026-08-05 08:00:59 |
| Symbol | TTRX |
| Name | TURN THERAPEUTICS INC. COMMON STOCK |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 29.79 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 263.33 / 9,586.08 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 250 N Westlake Blvd, Westlake Village, CA, United States, 91362
Phone: 818 546 4011
Website: https://turntherapeutics.com
Sector: Healthcare >> Biotechnology
Description: Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
Top Related Stocks
Stocks in the Same Sector
Healthcare › BiotechnologyAnalysed on the same criteria, ordered by market cap
Google